Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome-Reference-Cited by-同舟云学术

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome

Published:2016-08-27 Issue:48 Volume:7 Page:80083-80090
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Iurlo Alessandra¹,Nobili Alessandro²,Latagliata Roberto³,Bucelli Cristina¹,Castagnetti Fausto⁴,Breccia Massimo³,Abruzzese Elisabetta⁵,Cattaneo Daniele¹,Fava Carmen⁶,Ferrero Dario⁷,Gozzini Antonella⁸,Bonifacio Massimiliano⁹,Tiribelli Mario¹⁰,Pregno Patrizia¹¹,Stagno Fabio¹²,Vigneri Paolo¹²,Annunziata Mario¹³,Cavazzini Francesco¹⁴,Binotto Gianni¹⁵,Mansueto Giovanna¹⁶,Russo Sabina¹⁷,Falzetti Franca¹⁸,Montefusco Enrico¹⁹,Gugliotta Gabriele⁴,Storti Sergio²⁰,D’Addosio Ada M.²¹,Scaffidi Luigi⁹,Cortesi Laura²,Cedrone Michele²²,Rossi Antonella Russo²³,Avanzini Paolo²⁴,Mauro Endri²⁵,Spadea Antonio²⁶,Celesti Francesca²⁷,Giglio Gianfranco²⁸,Isidori Alessandro²⁹,Crugnola Monica³⁰,Calistri Elisabetta³¹,Sorà Federica³²,Rege-Cambrin Giovanna⁶,Sica Simona³²,Luciano Luigiana³³,Galimberti Sara³⁴,Orlandi Ester M.³⁵,Bocchia Monica³⁶,Tettamanti Mauro²,Alimena Giuliana³,Saglio Giuseppe⁶,Rosti Gianantonio⁴,Mannuccio Mannucci Pier³⁷,Cortelezzi Agostino¹

Affiliation:

1. Oncohematology Division, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation, University of Milan, Milan, Italy

2. Department of Neuroscience, IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy

3. Department of Cellular Biotechnologies and Hematology, University “La Sapienza” of Rome, Rome, Italy

4. Institute of Hematology “L. and A. Seràgnoli”, Department of Experimental, Diagnostic and Specialty Medicine, “S. Orsola-Malpighi” University Hospital, University of Bologna, Bologna, Italy

5. Hematology Unit, Sant'Eugenio Hospital, Rome, Italy

6. Division of Hematology and Internal Medicine, University of Turin, “San Luigi Gonzaga” University Hospital, Orbassano, Turin, Italy

7. Hematology Unit, University of Turin, Turin, Italy

8. Haematology, AOU Careggi, University of Firenze, Firenze, Italy

9. Department of Medicine, Section of Hematology, University of Verona, Verona, Italy

10. Division of Hematology and BMT, Azienda Ospedaliero - Universitaria di Udine, Udine, Italy

11. Hematology Unit, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy

12. Hematology Unit, Ferrarotto Hospital, Catania, Italy

13. Hematology Unit, Cardarelli Hospital, Naples, Italy

14. Hematology Unit, University of Ferrara, Ferrara, Italy

15. Hematology Unit, University of Padova, Padova, Italy

16. Department of Onco-Hematology, IRCCS-CROB, Rionero in Vulture, Italy

17. Hematology Unit, AOU G. Martino, Messina, Italy

18. Division of Hematology and Clinical Immunology, Department of Medicine, University of Perugia, Perugia, Italy

19. Hematology Unit, Sant'Andrea Hospital, Rome, Italy

20. Onco-Hematology Unit, Università Cattolica Giovanni Paolo II, Campobasso, Italy

21. Immunohematology and Trasfusional Medicine Division, S. Pietro Fatebenefratelli Hospital, Rome, Italy

22. Hematology Unit, S. Giovanni Hospital, Rome, Italy

23. Hematology and Transplants Unit, University of Bari, Bari, Italy

24. Hematology, Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia, Italy

25. Department of Internal Medicine, Pordenone General Hospital, Pordenone, Italy

26. Hematology and Stem Cell Transplantation Unit, Regina Elena Institute, Rome, Italy

27. Hematology Unit, Belcolle Hospital, Viterbo, Italy

28. Hematology Unit, Campobasso Hospital, Campobasso, Italy

29. Hematology Unit, Pesaro Hospital, Pesaro, Italy

30. Hematology and BMT Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy

31. Hematology Unit, Treviso Hospital, Treviso, Italy

32. Institute of Hematology, Università Cattolica Sacro Cuore, Rome, Italy

33. Hematology Unit, “Federico II” Hospital, University of Naples, Naples, Italy

34. Department of Clinical and Experimental Medicine, Section of Hematology - University of Pisa, Pisa, Italy

35. Oncology-Hematology Department, Hematology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

36. Hematology Unit, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy

37. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation and University of Milan, Milan, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choice of Frontline Tyrosine‐Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A “Campus CML” Study;European Journal of Haematology;2024-09-12

2. Current Status and Management of Chronic Myeloid Leukemia in the Gulf Region: Survey Results and Expert Opinion;Cancers;2024-05-31

3. Investigation of polypharmacy, antimicrobial-related potential drug–drug interactions in patients with hematological malignancies;Journal of Oncology Pharmacy Practice;2024-04-26

4. Challenges in management of older patients with chronic myeloid leukemia;Leukemia & Lymphoma;2024-04-23

5. Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia;Journal of Clinical Medicine;2024-01-03